Octapharma - clicking the octapharma logo will load the homepage
Terms of use
Expand Menu

 

Welcome to Octapharma!

Octapharma, a Swiss-based company, is an independent, global provider of human proteins for life-threatening diseases. Its core business is the development, production and sale of high quality human proteins including plasma derivatives and recombinant products.

The company was founded in 1983 by Mr. Wolfgang Marguerre and since then has grown to over 4,000 employees. Nowadays it has 37 subsidiaries and representative offices and is making sales in over 80 countries. Turnover in 2009 broke the record of Euro 1,000 million.

Octapharma continues to grow and invest heavily in the future. It owns five modern, state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico. Its profits are mainly channeled into R&D and further improvements and expansion of Production.


Octapharma Mission

Octapharma has established a clear and consistent mission:

For the safe and optimal use of human proteins

Over the past decade, in addition to our plasma-based activities, Octapharma has dedicated increasing resources to recombinant product research and development based on the use of human cell lines to treat life-threatening diseases.

Octapharma respects donated human plasma as a scarce and valuable resource. By using leading edge, validated viral inactivation and state-of-the-art purification technologies Octapharma aims to achieve the highest production yields and manufacture products with the highest possible safety margins. Octapharma is proud of having a immaculate safety record, never having been involved in any product liability case with its customers.


For the safe and optimal use of human proteins

Octapharma respects donated human plasma as a scarce and valuable resource. By using leading edge, validated viral inactivation and purification technologies Octapharma aims to achieve the highest production yields and produce products with the highest possible safety margins.